Veteran-Owned Dispensary Opens in Roselle, First in N.J. Social Equity Class
Roselle's new dispensary marks the state's first Black female disabled veteran-owned cannabis retail license under the social equity program.

Afro American woman working remotely on laptop and phone in urban café setting.
Opening Milestone in Social Equity Framework
The Roselle dispensary represents the first Black female disabled veteran-owned cannabis retail license approved by the New Jersey Cannabis Regulatory Commission (CRC). New Jersey's social equity program prioritizes applicants from communities disproportionately affected by cannabis prohibition, including disabled veterans and individuals from impact zones. The CRC has issued 146 dispensary licenses statewide as of May 2026. Social equity applicants account for approximately 30% of total licenses.
Roselle's location operates under the state's conditional and annual license framework, which requires applicants to meet capitalization, background, and operational readiness standards before commencing retail sales. Disabled veteran applicants receive priority scoring in the CRC's application rubric, adding 10 basis points to their composite score under the 2021 Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (CREAMM Act).
New Jersey's Social Equity Licensing Trajectory
New Jersey awarded its first wave of social equity licenses in Q2 2022, but capital access and real estate barriers delayed many openings until 2024 and 2025. The CRC's Medicinal and Adult Use Cannabis Business Licensing Rules, codified at N.J.A.C. 17:30, reserve 30% of all license classes for social equity and diversely owned businesses. As of May 2026, 44 social equity dispensaries have opened, compared to 102 standard licenses.
Impact Zone designation covers 327 census tracts in 176 municipalities, including Roselle in Union County. Impact Zone applicants receive automatic social equity status if they meet residency and ownership thresholds. Disabled veterans qualify separately under N.J.S.A. 24:6I-36, which mandates priority review and fee waivers for service-disabled veteran-owned businesses.
Roselle Market Context and Competition
Roselle's new dispensary enters a Union County market with seven existing retail licenses, including two within a three-mile radius. Union County generated $47.2 million in adult-use cannabis sales in Q1 2026, ranking fifth among New Jersey's 21 counties, according to CRC quarterly reports. Per-capita sales run at $81 annually. That's below the state average of $94.
Roselle imposed a 2% local cannabis tax in 2023, the maximum permitted under N.J.S.A. 40:48I-1. That levy stacks on top of the state's 6.625% sales tax and the CRC's tiered excise structure, which ranges from 10% to 25% depending on wholesale price. Effective all-in tax rates in Roselle run between 18.6% and 33.6%, depending on product category and wholesale cost.
Capital and Operational Challenges for Social Equity Licensees
Social equity applicants in New Jersey face average startup costs of $1.8 million to $3.2 million, including real estate, inventory, security, and legal fees. The CRC's Social Equity Excise Fee Relief Program, launched in January 2024, defers 100% of state excise taxes for the first 24 months of operation for qualifying businesses. That program has enrolled 38 dispensaries and 12 cultivation licenses as of April 2026.
Many social equity operators struggle with 280E tax burdens at the federal level, which disallow ordinary business deductions for cannabis businesses, even with fee relief. A 2025 analysis by the New Jersey CannaBusiness Association found that social equity dispensaries pay an effective federal tax rate of 68% to 74%, compared to 21% for non-plant-touching businesses. Federal rescheduling to Schedule III, if finalized by the DEA, would eliminate 280E. That'd reduce the burden by an estimated 40 to 50 percentage points.
Veteran Participation in Cannabis Industry
Veteran-owned cannabis businesses account for less than 4% of all U.S. state licenses, despite veteran preference laws in 14 states. New Jersey's veteran priority framework, enacted under the CREAMM Act, awards 10 additional points in the CRC's 100-point application scoring system. Disabled veterans also qualify for expedited review, with a statutory 60-day decision window compared to the standard 90-day timeline.
New Jersey doesn't publish demographic breakdowns of veteran licensees by race or gender, but industry surveys estimate that Black women represent less than 2% of all veteran-owned cannabis businesses nationwide. The Roselle opening is the first publicly documented instance in New Jersey of a Black female disabled veteran receiving a dispensary license.
What's Next for New Jersey Social Equity
The CRC is scheduled to release its 2026 Social Equity Impact Report in June, including updated license counts and capital access data. The report will detail the performance of the state's $10 million Social Equity Loan Fund, which provided zero-interest loans to 18 applicants in 2025. Legislative proposals pending in Trenton would expand the fund to $25 million and extend tax relief from 24 to 36 months.
For full background on New Jersey's social equity framework and licensing data, see the CannIntel topic hub on the New Jersey Social Equity Program. The CRC's next quarterly license update is scheduled for June 15, 2026.
Frequently asked questions
What is New Jersey's social equity cannabis program?
New Jersey's social equity program reserves 30% of all cannabis licenses for applicants from communities disproportionately affected by prohibition, including Impact Zone residents, disabled veterans, and women- or minority-owned businesses. The program offers fee waivers, expedited review, and 24-month excise tax deferrals.
How many social equity dispensaries operate in New Jersey?
As of May 2026, 44 social equity dispensaries have opened in New Jersey out of 146 total licensed dispensaries. The Cannabis Regulatory Commission's rules mandate that 30% of all license classes go to social equity applicants.
What are the startup costs for a cannabis dispensary in New Jersey?
Social equity dispensary applicants face average startup costs between $1.8 million and $3.2 million, covering real estate, inventory, security systems, legal compliance, and licensing fees. The state offers zero-interest loans through a $10 million Social Equity Loan Fund.
What tax relief do New Jersey social equity cannabis businesses receive?
Qualifying social equity operators receive 100% deferral of state excise taxes for the first 24 months of operation under the CRC's Social Equity Excise Fee Relief Program. However, they remain subject to federal 280E tax rules, which disallow ordinary business deductions.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

Innovative Industrial Properties Posts Q1 Revenue Gain as Occupancy Holds
Cannabis REIT reports first-quarter results with rental income growth and stable tenant base despite sector headwinds.

Missouri Cannabis Workers File Union Election After NLRB Ruling
Federal labor decision opens door for multistate organizing push across dispensaries and cultivation facilities.

Canopy Growth Stock Declines as Investor Caution Persists
Recent share-price weakness hasn't changed the fundamental thesis for Canada's largest cannabis company.
More from the newsroom

TSA Clarifies Medical Marijuana Air Travel Policy: FDA-Approved Only
Federal agency reiterates passengers may carry FDA-approved cannabis products through security, but state-legal marijuana remains prohibited.

Federal Marijuana Legalization Unlikely in 2026 Despite Rescheduling Push
DEA rescheduling timeline extends into 2027 while congressional legalization bills remain stalled in committee.

Thailand Cannabis Market Survives New Restrictions, Sales Steady
Six months after Thailand's medical-only cannabis law took effect, retail sales and dispensary counts remain near pre-regulation highs.